Evidence map›Paper›PMID 38067615›Full record

ArticleMolecules (Basel, Switzerland)2023

In Vitro Evidence of Selective Pro-Apoptotic Action of the Pure Cannabidiol and Cannabidiol-Rich Extract.

Paweł Śledziński, Agnieszka Nowak-Terpiłowska, Piotr Rzymski, Ryszard Słomski, Joanna Zeyland

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Paweł ŚledzińskiDepartment of RNA Structure and Function, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.ORCID 0000-0002-4671-5189
Agnieszka Nowak-TerpiłowskaDepartment of Biochemistry and Biotechnology, Poznań University of Life Sciences, Dojazd Street 11, 60-632 Poznan, Poland.ORCID 0000-0002-4844-3121
Piotr RzymskiDepartment of Environmental Medicine, Poznań University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0002-4713-0801
Ryszard SłomskiInstitute of Human Genetics, Polish Academy of Sciences, Strzeszyńska Street 32, 60-479 Poznan, Poland.ORCID 0000-0001-5601-7002
Joanna ZeylandDepartment of Biochemistry and Biotechnology, Poznań University of Life Sciences, Dojazd Street 11, 60-632 Poznan, Poland.ORCID 0000-0002-1208-3291
University of Life Sciences in Poznań · PLInstitute of Bioorganic Chemistry, Polish Academy of Sciences · PLInstitute of Human Genetics · PLPoznan University of Medical Sciences · PL

Funding

National Centre for Research and Development INNOMED/I/11/NCBR/201
6 · The paper itself

Abstract

Plant cannabinoids, secondary metabolites of species belonging to the

Indexed as

CannabidiolCannabinoidsCannabisHallucinogensEndocannabinoidsHumansMalePlant ExtractsCannabidiolCannabinoidsEndocannabinoidsHallucinogensPlant ExtractsapoptosiscancercannabidiolcannabinoidsCannabisCBD

Identifiers

PMID38067615
PMCPMC10708261
OpenAlexW4389238256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.